Abstract:Background. Several studies have demonstrated that acetylation was involved in the process of liver cancer. This study aimed to establish an effective predictive prognostic model using acetylation regulation genes in liver cancer. Methods. Two datasets were downloaded from the Cancer Genome Atlas (TCGA) database and International Cancer Genome Consortium (ICGC) database. Differentially expressed acetylation regulation genes were identified in the TCGA-LIHC dataset, and then, Gene Ontology (GO) functional annotation analysis was used to investigate the molecular mechanism. After grouping the patients into clusters based on consensus clustering, we explored the correlation between clusters and clinical characteristics. A risk model was constructed by the least absolute shrinkage and selection operator (LASSO) regression analysis to calculate the risk score. Patients were divided into high-risk and low-risk groups according to the risk score using the acetylation regulation genes. Data downloaded from LIRI-JP were used for external validation. Univariate and multivariate Cox regressions were performed to identify independent risk factors. A prognostic nomogram was constructed according to the TCGA-LIHC dataset. The effect of HDAC11 expression on the proliferation and migration of liver cancer was detected by the CCK-8 method and cell scratch test, respectively. Results. Eleven of 29 acetylation regulation genes were identified as upregulated differentially expressed genes. Go enrichment analysis showed that they were involved in "protein and histone deacylation and deacetylation." Patients were categorized into two clusters according to the expression of 29 acetylation regulation genes. Compared with cluster 2, cluster 1 correlated with shorter overall survival (OS) and higher expression. Stage, T stage, grade, gender, age, and follow-up state were significantly different between two clusters. Pathways involved in DNA repair were significantly enriched in cluster 1. The risk score was calculated by HDAC1, HDAC2, HDAC4, HDAC11, HAT1, and SIRT6. Patients in the high-risk group had a worse prognosis in both datasets. Risk score was not only an independent prognostic marker but could also predict the clinicopathological features of liver cancer. A nomogram containing risk score, T stage, and M stage was built to predict overall survival. After transfection with HDAC11 overexpression plasmid, the proliferation ability of HepG2 cells increased, while the migration ability had no change. Conclusions. Our findings suggested that acetylation regulation genes contribute to malignant progression and have a clinical prognostic impact on liver cancer.

Expression of HDAC 4 in hepatocellular carcinoma and its correlation with prognosis

Expression of HDAC4 in human lung adenocarcinoma and its relationship with chemotherapy resistance

Identification of ADH4 As a Novel and Potential Prognostic Marker in Hepatocellular Carcinoma

Profiles of Acetylation Regulation Genes Contribute to Malignant Progression and Have a Clinical Prognostic Impact on Liver Cancer

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma

ADH4-a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications

Study on the Relationship Between the Expression of HDAC1 and Oct4 in Intestinal-Type Gastric Cancer

Identification of CFHR4 Associated with Poor Prognosis of Hepatocellular Carcinoma

Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma.

HDAC4 Promotes Nasopharyngeal Carcinoma Progression and Serves As a Therapeutic Target

Identification of target genes co-regulated by four key histone modifications of five key regions in hepatocellular carcinoma

KLF4 Loss in Hepatocellular Carcinoma: Improving Prognostic Prediction and Correlating Immune Infiltrates

Identification of Histone Deacetylase 3 As a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-associated Hepatocellular Carcinoma.

Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.

Silencing HSF4 Can Inhibit the Proliferation of HCC Cells

OCT 4 expression in hepatocellular carcinoma and its clinical significance

Correlation between HDAC 6 expression and clinical features of renal cell carcinoma

Clinicopathological Significance of Stat4 in Hepatocellular Carcinoma and Its Effect on Cell Growth and Apoptosis

Low SAA4 gene expression is associated with advanced HCC stage and a poor prognosis

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

Cytoskeleton-associated Membrane Protein4 is Upregulated in Tumor Tissues and is Associated with Clinicopathological Characteristics and Prognosis in Hepatocellular Carcinoma